EP1150684A4 - Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes - Google Patents

Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes

Info

Publication number
EP1150684A4
EP1150684A4 EP00911738A EP00911738A EP1150684A4 EP 1150684 A4 EP1150684 A4 EP 1150684A4 EP 00911738 A EP00911738 A EP 00911738A EP 00911738 A EP00911738 A EP 00911738A EP 1150684 A4 EP1150684 A4 EP 1150684A4
Authority
EP
European Patent Office
Prior art keywords
bone
autografic
allogeneic
xenografic
resorptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00911738A
Other languages
German (de)
English (en)
Other versions
EP1150684A1 (fr
Inventor
John H Healey
Gene R Diresta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of EP1150684A1 publication Critical patent/EP1150684A1/fr
Publication of EP1150684A4 publication Critical patent/EP1150684A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112—Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
EP00911738A 1999-02-09 2000-02-09 Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes Withdrawn EP1150684A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11926099P 1999-02-09 1999-02-09
US119260P 1999-02-09
PCT/US2000/003285 WO2000047214A1 (fr) 1999-02-09 2000-02-09 Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes

Publications (2)

Publication Number Publication Date
EP1150684A1 EP1150684A1 (fr) 2001-11-07
EP1150684A4 true EP1150684A4 (fr) 2005-06-15

Family

ID=22383420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00911738A Withdrawn EP1150684A4 (fr) 1999-02-09 2000-02-09 Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes

Country Status (5)

Country Link
EP (1) EP1150684A4 (fr)
JP (1) JP2002536123A (fr)
AU (1) AU776555B2 (fr)
CA (1) CA2360319A1 (fr)
WO (1) WO2000047214A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410043B1 (en) 1998-05-07 2002-06-25 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6632447B1 (en) 1998-05-07 2003-10-14 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
EP1383509A4 (fr) * 2001-04-03 2005-10-26 Royal Alexandra Hosp Children Medicament a utiliser en matiere de greffe osseuse
EP1450874A2 (fr) * 2001-11-29 2004-09-01 Kathy Rzeszutek Implants osseux a resorption regulee
FR2836681B1 (fr) * 2002-03-04 2004-06-18 Centre Nat Rech Scient Compose phosphocalcique modifie, composition injectable le contenant
IL153699A (en) 2002-12-26 2008-11-26 Prochon Biotech Ltd The composition for transplantation basically
GB0307834D0 (en) * 2003-04-04 2003-05-14 Ta Contrast Ab Composition
WO2005055723A1 (fr) 2003-12-04 2005-06-23 The University Of Iowa Research Foundation Gallium d'inhibition de formation de films biologiques
JP5167538B2 (ja) * 2005-05-16 2013-03-21 国立大学法人 東京医科歯科大学 骨セメントおよび歯科補綴物
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
EP1958649A1 (fr) 2007-02-14 2008-08-20 Graftys Ciment calcium-phosphate injectable libérant un inhibiteur de la résorption osseuse
WO2009006921A1 (fr) * 2007-07-10 2009-01-15 Barrera Jose Bouza Substance microporeuse pour implant chirurgical
WO2009134856A2 (fr) * 2008-04-30 2009-11-05 Genta Incorporated Compositions pharmaceutiques à base de gallium et procédés associés
EP2228080A1 (fr) * 2009-03-03 2010-09-15 Graftys Biomatériaux de phosphate de calcium au gallium
WO2013043529A1 (fr) 2011-09-19 2013-03-28 Emory University Activation de la voie de la protéine morphogénétique osseuse, compositions pour ossification et méthodes associées
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
DE102016209988A1 (de) * 2016-06-07 2017-12-07 Heraeus Medical Gmbh Pastenförmiger Zweikomponenten-Polymethylmethacrylat-Knochenzement
CN109010334A (zh) * 2018-09-05 2018-12-18 杭州市萧山区中医院 聚甲基丙烯酸甲酯复合辛伐他汀骨水泥用于制备假体周围骨溶解和炎症反应的药物中的应用
CN109010909A (zh) * 2018-09-05 2018-12-18 杭州市萧山区中医院 聚甲基丙烯酸甲酯复合红霉素骨水泥用于防治假体周围骨溶解和炎症反应的应用
CN111321403B (zh) * 2020-03-10 2022-03-11 河北北方学院 一种基于多巴胺的锌表面载镓-氧化石墨烯复合涂层的制备方法
CN113181425A (zh) * 2021-04-28 2021-07-30 北京邦塞科技有限公司 骨水泥固相粉料、骨水泥及其制备方法和应用
CN114984310B (zh) * 2022-06-30 2023-09-08 西安理工大学 一种抗溃散吸水膨胀有机-无机复合骨水泥及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039107A1 (fr) * 1995-06-06 1996-12-12 Merck & Co., Inc. Composition a base de ciment de bisphosphonate permettant d'eviter le relachement aseptique des protheses orthopediques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
WO1996039203A1 (fr) * 1995-06-06 1996-12-12 Gensci Regeneration Laboratories, Inc. Materiaux osteogeniques modifies
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039107A1 (fr) * 1995-06-06 1996-12-12 Merck & Co., Inc. Composition a base de ciment de bisphosphonate permettant d'eviter le relachement aseptique des protheses orthopediques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0047214A1 *

Also Published As

Publication number Publication date
WO2000047214A9 (fr) 2002-04-11
EP1150684A1 (fr) 2001-11-07
AU776555B2 (en) 2004-09-16
AU3358800A (en) 2000-08-29
JP2002536123A (ja) 2002-10-29
CA2360319A1 (fr) 2000-08-17
WO2000047214A1 (fr) 2000-08-17

Similar Documents

Publication Publication Date Title
EP1150684A4 (fr) Ciments osseux anti-resorption et implants osseux allogenes, autogreffes et xenogreffes
EP1180000A4 (fr) Greffe prothetique
AU2001259154A1 (en) Bone fixation system
DE69929513D1 (de) Knochenprothese
GB0014079D0 (en) Orthopaedic implant
HK1062999A1 (en) Bone fixation system.
HUP0200409A2 (en) Valdecoxib compositions, process for their preparation and their use
AU2001255846A8 (en) Dental implant system
AU7994300A (en) Nell-1 enhanced bone mineralization
GB0027542D0 (en) Silicone cosmesis
GB9920785D0 (en) Bone splint
GB9812103D0 (en) Surgical implant
MXPA02001613A (es) Material y metodos para incremento de tejido.
AU1854401A (en) Bone implant
GB9926231D0 (en) Medical implants
GB9924959D0 (en) Implant alignment
GB9928837D0 (en) Novel bone cement
AU2002321019A1 (en) Bone implant
GB9910377D0 (en) Tissue engineering
GB2347865B (en) Cotyloid prosthesis
HUP0004776A3 (en) Prosthesis system
IL143990A0 (en) Bone stimulating factor
EP1194439A4 (fr) Eag2 d'origine humaine
GB0130539D0 (en) Bone marrow-specific protein
AU137973S (en) Implant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20050425

17Q First examination report despatched

Effective date: 20060224

17Q First examination report despatched

Effective date: 20060224

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20081126